Professor Elam

Friday Nov 6, 2015

Questions continue to swirl if Michael Pearson can operate Valiant Pharma.

It has shed some $3 B in market value since its top a few months back. There are questions surrounding its accounting and financial practices with companies that sell its products. This is  the meaning of good governance and the absence of managed earnings. Once social mood turns against such practices, it is hard to get the proverbial ox out of the ditch.